美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
16714-151-01	16714-151	HUMAN PRESCRIPTION DRUG	Tiagabine Hydrochloride	Tiagabine Hydrochloride	TABLET	ORAL	20211124	N/A	ANDA	ANDA214816	Northstar Rx LLC	TIAGABINE HYDROCHLORIDE	2 mg/1	30 TABLET in 1 BOTTLE (16714-151-01)
16714-152-01	16714-152	HUMAN PRESCRIPTION DRUG	Tiagabine Hydrochloride	Tiagabine Hydrochloride	TABLET	ORAL	20211124	N/A	ANDA	ANDA214816	Northstar Rx LLC	TIAGABINE HYDROCHLORIDE	4 mg/1	30 TABLET in 1 BOTTLE (16714-152-01)
16714-153-01	16714-153	HUMAN PRESCRIPTION DRUG	Tiagabine Hydrochloride	Tiagabine Hydrochloride	TABLET	ORAL	20211124	N/A	ANDA	ANDA214816	Northstar Rx LLC	TIAGABINE HYDROCHLORIDE	12 mg/1	30 TABLET in 1 BOTTLE (16714-153-01)
16714-154-01	16714-154	HUMAN PRESCRIPTION DRUG	Tiagabine Hydrochloride	Tiagabine Hydrochloride	TABLET	ORAL	20211124	N/A	ANDA	ANDA214816	Northstar Rx LLC	TIAGABINE HYDROCHLORIDE	16 mg/1	30 TABLET in 1 BOTTLE (16714-154-01)
72205-084-30	72205-084	HUMAN PRESCRIPTION DRUG	Tiagabine Hydrochloride	Tiagabine Hydrochloride	TABLET	ORAL	20211123	N/A	ANDA	ANDA214816	Novadoz Pharmaceuticals LLC	TIAGABINE HYDROCHLORIDE	2 mg/1	30 TABLET in 1 BOTTLE (72205-084-30)
72205-085-30	72205-085	HUMAN PRESCRIPTION DRUG	Tiagabine Hydrochloride	Tiagabine Hydrochloride	TABLET	ORAL	20211123	N/A	ANDA	ANDA214816	Novadoz Pharmaceuticals LLC	TIAGABINE HYDROCHLORIDE	4 mg/1	30 TABLET in 1 BOTTLE (72205-085-30)
72205-086-30	72205-086	HUMAN PRESCRIPTION DRUG	Tiagabine Hydrochloride	Tiagabine Hydrochloride	TABLET	ORAL	20211123	N/A	ANDA	ANDA214816	Novadoz Pharmaceuticals LLC	TIAGABINE HYDROCHLORIDE	12 mg/1	30 TABLET in 1 BOTTLE (72205-086-30)
72205-087-30	72205-087	HUMAN PRESCRIPTION DRUG	Tiagabine Hydrochloride	Tiagabine Hydrochloride	TABLET	ORAL	20211123	N/A	ANDA	ANDA214816	Novadoz Pharmaceuticals LLC	TIAGABINE HYDROCHLORIDE	16 mg/1	30 TABLET in 1 BOTTLE (72205-087-30)